دورية أكاديمية

Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project

التفاصيل البيبلوغرافية
العنوان: Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries - The ADVANCE project
المؤلفون: BRAEYE, Toon, Emborg, Hanne-Dorthe, Llorente-Garcia, Ana, Huerta, Consuelo, Martin-Merino, Elisa, Duarte-Salles, Talita, Danieli, Giorgia, Tramontan, Lara, Weibel, Daniel, McGee, Chris, Villa, Marco, Gini, Rosa, Lehtinen, Matti, Titievsky, Lina, Sturkenboom, Miriam
المساهمون: BRAEYE, Toon, Emborg, Hanne-Dorthe, Llorente-Garcia, Ana, Huerta, Consuelo, Martin-Merino, Elisa, Duarte-Salles, Talita, Danieli, Giorgia, Tramontan, Lara, Weibel, Daniel, McGee, Chris, Villa, Marco, Gini, Rosa, Lehtinen, Matti, Titievsky, Lina, Sturkenboom, Miriam
المصدر: Article
بيانات النشر: ELSEVIER SCI LTD
سنة النشر: 2020
المجموعة: Document Server@UHasselt (Universiteit Hasselt)
مصطلحات موضوعية: Vaccination coverage, Influenza vaccines, Papillomavirus vaccines, Measles vaccines, Probability
الوصف: Background: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public-private collaboration aiming to develop and test a system for rapid benefit-risk monitoring of vaccines using existing healthcare databases in Europe. We estimated vaccine coverage from electronic healthcare databases as part of a fit-for-purpose assessment for vaccine benefit-risk studies. Methods: A retrospective dynamic cohort study was conducted through a distributed network approach. Coverage with measles-vaccine for birth year 2006, human papillomavirus (HPV)-vaccine for birth years 1990-2000 and influenza-vaccine for birth years 1920-1950 was estimated using period-prevalence and inverse probability weighting methods. Seven databases from four countries participated: Italy (Pedianet, Val Padana), Spain (BIFAP, SIDIAP), UK (RCGP-RSC, THIN), Denmark (SSI/AUH). Database access providers extracted the data, transformed it into a common structure and ran an R-script locally. The created output tables were shared and pooled at a central server. Results: The total study population comprised 274,616 persons for measles-vaccine, 2,011,666 persons for HPV-vaccine and 14,904,033 persons for influenza-vaccine. Measles-vaccine coverage varied from 84.3% (Denmark) to 96.5% (Italy, Val Padana) for the first dose and from 82.8% (Italy, Val Padana) to 90.9% (UK) for the second dose at the age of 7 years. The HPV-vaccine coverage, aggregated over birth years 1997-2000, ranged from 60% (UK) to 88.3% (Denmark) at the age of 15 years. The influenza-vaccine coverage for the influenza seasons from 2009 to 2015 for persons aged 65 years and more was roughly stable around 43% in Denmark and around 68% in the UK while a decrease from 58 to 50% was observed in Catalonia (Spain). Conclusions: We obtained detailed, age-specific coverage estimates though a common procedure. We discussed between database comparability and comparability to published national estimates. ; The Innovative Medicines Initiative Joint Undertaking ...
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 0264-410X
1873-2518
العلاقة: VACCINE, 38 (16) , p. 3243 -3254; http://hdl.handle.net/1942/31187Test; 3254; 16; 3243; 38; WOS:000525317600011
DOI: 10.1016/j.vaccine.2020.02.082
الإتاحة: https://doi.org/10.1016/j.vaccine.2020.02.082Test
http://hdl.handle.net/1942/31187Test
رقم الانضمام: edsbas.A997A2E0
قاعدة البيانات: BASE
الوصف
تدمد:0264410X
18732518
DOI:10.1016/j.vaccine.2020.02.082